E-Magic Plus received registration approval in India last year
Eurocor GmbH, a group company of Opto Circuits (India) has announced that the E-Magic Plus Sirolimus Eluting Coronary Stent System, has received CE (Conformité Européenne) Mark approval.
E-Magic Plus is providing the latest technology in combining ultra-thin strut of a CoCr stent, with an optimal Sirolimus coating. Fully biodegradable polymer is minimizing delayed healing and late adverse events.
Mr Vinod Ramnani, CMD of Opto Circuits said, "The CE mark approval of E-Magic Plus, represents a key milestone for Eurocor GmbH. We are now back in the largest cardiovascular product range, the DES. Thanks to its innovative technology, we'll be able to further expand treatment options for patients with introduction of E-Magic Plus - highly differentiated DES with Sirolimus Coating and biodegradable polymer."
E-Magic Plus received registration approval in India last year and has been available for sale for few months already.
With this approval, Eurocor GmbH is preparing to make the E-Magic Plus commercially available in Europe and other markets where CE Mark approval can expedite the registration process.